Viking Therapeutics is developing drugs for obesity and non-alcoholic fatty liver disease. The company has no revenue and may have none for several years as it works to get drug approval. Viking ...

Monopoly Go players who need extra tokens to progress through the latest Adventure Club event should give Viking Voyage a go. This new Monopoly Go event launched alongside the return of the ...

Viking soared more than 100% in one trading session last year on positive clinical trial news. The stock has since given up those gains, but its weight loss drug program continues to advance and ...

Demand for Viking cruises remains high, with the company setting new revenue and booking records so far in 2025. “Bookings continue to break records, with January 31 setting a new all-time high for ...

Obesity upstart Viking Therapeutics has agreed to pay a total of $150 million through 2028 to enlist CordenPharma for production of its dual GIP/GLP-1 agonist VK2735. Under the deal, CordenPharma ...

Viking will continue to grow its fleet, with the addition of 26 river ships and nine ocean ships by 2030. Photo Credit: Viking Viking Holdings told investors Tuesday during its Q4 earnings call ...

New discoveries are breaking old assumptions about Viking women, rewriting history by restoring them to their rightful place on the battlefield. An artist recreates what a Viking woman warrior ...

Viking Fiction’s changes to its acquiring team include Edward Kirke being promoted to commissioning editor, effective immediately. Viking said: “Since joining Viking [as editor] in May 2023 ...

Viking skulls reveal severe morbidity Date: February 21, 2025 Source: University of Gothenburg Summary: Sweden's Viking Age population appears to have suffered from severe oral and maxillofacial ...